Published Date: 2019-06-19 | Pages: Ongoing | Tables: Ongoing | Report ID: 7277
Industry: Life Science
Over the last decade, the global dental industry has endured a sweeping transformation. Considering the rising dental issues amongst the patients such as dental implants and denatures several advancements have been made in the past. Although there are many major advancements made in the field of dentistry, the emotional connection with natural teeth has compelled for the development of tooth regeneration therapy.
Journal of Clinical Periodontology has recently mentioned that the results of tooth regenerative therapy in infrabony defects are stable for more than 5-years and orthodontists may rely on the teeth treated with regenerative techniques in the long term. The journal has further mentioned regenerative treatment is gingivally healthy.
Efforts behind the Report
A realistic research methodology accompanied by a comprehensive approach is the foundation of valued insights provided in the global tooth regeneration market for the projected period of 2018-2025. QY Research’s report on global tooth regeneration market includes in-depth information on the key market dynamics and revenue growth prospects of tooth regeneration industry and also provides insightful forecast analysis of tooth regeneration market.
In an attempt to collect actionable acumen into the projection analysis of the global tooth regeneration market, the expert team of analysts dedicatedly working in the healthcare domain of QY Research has employed detail primary and secondary research. Company’s in-house professionals did thorough cross-validation of this report to make it one-of-its-own-kind with extreme integrity and reliability.
Challenges in Tooth Regeneration Market
● Finding a suitable cell source for the application in a patient is one of the most significant hurdles in the growth of global tooth regeneration market. Additionally, after an expansion of vitro, the embryonic stem may drop its quality of odontogenic potency and are not useful for the regeneration.
● Another challenge faced by the tooth regeneration industry is getting clinically feasible cell source. It’s a challenging job to isolate and develop Autologous post-natal cells in vitro which are extracted from tooth germs. These cells might not be feasible for clinical use.
● Speeding up the entire tooth regeneration development process by gene-manipulation is the other factor which is creating a negative impact on the global tooth regeneration market.
Symbiosis- DENTSPLY Implants’ Innovative Product for Regeneration
Globe’s largest professional dental solutions manufacturer, DENTSPLY Implants came up with a new product which helps in oral bones and soft tissue regeneration that provides safety to the patients. Symbiosis is designed for a wide range of various types of therapies and implants, which promote long term outcome and regeneration process. Apart from this key player, several new companies arose in the globe to capitalize and address on extremely beneficial opportunities in the tooth regeneration market. Universities and dental industry leaders are also taking efforts to develop innovative solutions and products to develop new teeth.
Global Tooth Regeneration Market: Segmentation
● Middle Aged
As the geriatric population has fewer teeth, the geriatric segment is likely to lead the global tooth regeneration market during the projected period. On the basis of application, the dentin segment is expected to grab a larger share of the market due to growing demand for tooth regeneration in cosmetic surgery.
Global tooth regeneration market is likely to grow well in the Asia Pacific region as India and China are its major growth countries. On the other hand, Europe and North America regions are likely to lose its position to the Asia Pacific due to increasing geriatric population in the Asia Pacific Region.
Following are some of the key players operating in the global tooth regeneration market:
Cook Group Incorporated, Institut Straumann AG, BioMimetic Therapeutics, Inc., Institut Straumann AG, BioMimetic Therapeutics, Inc., Institut Straumann AG, Integra LifeSciences, DENTSPLY Implants, CryoLife, Inc., StemCells Inc., Unilever, Ocata Therapeutics, and Datum Dental.
NOTE - The analysis, thoughts, views, facts, and opinions expressed in this report are of the respective research analysts. QYR Consulting does not necessarily endorse it or it is also not essentially formal views of QYR Consulting.
Life sciences is a wide branch of study that is gradually becoming an integral industry to the global economics. QYR Consulting looks at the steady transformation of the life sciences industry and its impact on the subindustries such as medical care, pharmaceutical, and medical devices. Our team of esteemed analysts have put together reports to analyze the monumental changes life sciences is expected to bring in the overall healthcare industry. These reports identify the exact turning points for the industry and open up a platform for discussing its growth.
QYR Consulting brings to you a structured analysis of the technological advancements so far, vision of the players in the industry, and the strategies they are likely to use to make their mark. The reports dissect various components of the life sciences industry to scrutinize the influential factors. To help the readers make profitable business decisions, analysts have highlighted the lucrative investment areas and upcoming business opportunities.
Request for data as per your requirement
Get specifications suitable to your business
Receive an in-depth and unique understanding of the subject matter
Acquire insight into specific area of the industry